Quantitative Biomedical Imaging Group
Professor James O'Connor's group identify, validate and translate new imaging biomarkers to test new therapies and to improve the management of patients with cancer.
Professor James O'Connor
Group Leader:
Quantitative Biomedical Imaging
Professor James O'Connor uses MRI and other imaging modalities to develop and validate imaging biomarkers of tumour structure and function. He is a specialist in cross sectional radiology and is a Fellow of the Royal College of Radiologists.
Researchers in this group
.
Recent discoveries from this group
A special type of MRI scan where patients inhale 100% oxygen could result in lower radiotherapy doses for some cancer patients.
Imaging researchers have taken a major step towards their ultimate goal of identifying cancers that are starved of oxygen so that altered treatment can be used to target them more effectively.